Compare CREG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CREG | HBIO |
|---|---|---|
| Founded | N/A | 1901 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 25.7M |
| IPO Year | 2019 | 2000 |
| Metric | CREG | HBIO |
|---|---|---|
| Price | $0.34 | $5.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 4.7M | 295.9K |
| Earning Date | 03-27-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $867,431.00 | ★ $116,176,000.00 |
| Revenue This Year | N/A | $9.13 |
| Revenue Next Year | N/A | $4.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12953.89 | N/A |
| 52 Week Low | $0.20 | $0.28 |
| 52 Week High | $2.66 | $5.25 |
| Indicator | CREG | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 17.24 | 94.71 |
| Support Level | $0.20 | $0.46 |
| Resistance Level | $1.47 | N/A |
| Average True Range (ATR) | 0.26 | 0.21 |
| MACD | -0.08 | 0.57 |
| Stochastic Oscillator | 5.21 | 97.01 |
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.